Multicenter Efficacy Study of Recombinant Human Erythropoietin in Acute Ischemic Stroke

Clinical trial NCT00604630 · COMPLETED

Trial details

NCT number: NCT00604630
Sponsor: Max-Planck-Institute of Experimental Medicine
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Infarction, Middle Cerebral Artery Middle Cerebral Artery Stroke Stroke, Acute

Start date: 2003-01-01
Primary completion: 2008-06-01
Enrollment: 522

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.